NEWSROOM

Pharmaceutical

PRISM MediaWire – Weekly Press Resume – Nov. 13 to Nov. 17, 2023

PRISM MediaWire – Weekly Press Resume – Nov. 13 to Nov. 17, 2023

New York, Nov. 17, 2023 PRISM MediaWire - Weekly Press Resume Nov. 13 to Nov. 17, 2023 Ethical Web AI Launches AI Seek 4.0 with Almost Real-Time Data https://prismmediawire.com/ethical-web-ai-launches-ai-seek-4-0-with-almost-real-time-data/ AmpliTech to Host Quarterly Investor Call to Review Q3 2023 Earnings on Tuesday November 14, 4:30 PM ET; Dial-in # 1-833-630-0019 or 1-412-317-1807...

read more
PRISM MediaWire – Weekly Press Resume – Nov. 13 to Nov. 17, 2023

PRISM MediaWire – Weekly Press Resume – Nov. 6 to Nov. 10, 2023

New York, New York, Nov. 10, 2023 PRISM MediaWire - Weekly Press Resume Nov. 6 to Nov. 10, 2023 Two Hands Corporation Launches Sports Illustrated Line Protein Bars in Canada https://prismmediawire.com/two-hands-corporation-launches-sports-illustrated-line-protein-bars-in-canada/ BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023...

read more
Lipella Pharmaceuticals Granted FDA Orphan Designation for Oral Graft-versus-Host Disease Drug

Lipella Pharmaceuticals Granted FDA Orphan Designation for Oral Graft-versus-Host Disease Drug

“GvHD affects approximately 30,000 Americans and oral GvHD causes significant oral pain and discomfort, making it difficult for patients to eat, drink and speak. Oral GvHD is a great unmet need in cancer survivors.” Dr. Michael Chancellor, Chief Medical Officer at Lipella Pharmaceuticals Pittsburgh, PA, November 10, 2023 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our, “us” or the “Company”), has received Orphan Drug Designation for its LP-310 drug candidate for oral...

read more
PRISM MediaWire – Weekly Press Resume – Oct. 30 to Nov. 3, 2023

PRISM MediaWire – Weekly Press Resume – Oct. 30 to Nov. 3, 2023

New York, New York, Nov. 3, 2023 PRISM MediaWire - Weekly Press Resume Oct. 30 to Nov. 3, 2023 Metatron Pioneers Real-Time Stock Insights with AI-Enhanced Stock Trendz https://prismmediawire.com/metatron-pioneers-real-time-stock-insights-with-ai-enhanced-stock-trendz/ PRISM MarketView Highlights Its Spooktacular Zombie Index For Halloween https://prismmediawire.com/prism-marketview-highlights-its-spooktacular-zombie-index-for-halloween/ Franklin Mining Bolivia (a branch of Franklin Mining,...

read more
PRISM MediaWire – Weekly Press Resume – Oct. 23 to Oct. 27, 2023

PRISM MediaWire – Weekly Press Resume – Oct. 23 to Oct. 27, 2023

New York, New York, October 27, 2023 PRISM MediaWire - Weekly Press Resume Oct. 23 to Oct. 27, 2023 Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference https://prismmediawire.com/lipella-pharmaceuticals-to-present-at-the-fall-foliage-microcap-rodeo-conference/ Metatron Partners with MML Marketing, Boasting a Proven Track Record of $19M in Sales https://prismmediawire.com/metatron-partners-with-mml-marketing-boasting-a-proven-track-record-of-19m-in-sales/ Argentum...

read more
Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference

Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference

Pittsburgh, PA, October 23, 2023 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our, “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, will present at the 2023 virtual Fall Foliage MicroCap Rodeo Conference to be held from October 24th - 27th. Dr. Jonathan Kaufman, CEO of Lipella, said: “2023 continues to be a year of significant milestone achievements for Lipella. Early in the year, we were delighted to report...

read more

Categories

Loading
Translate »